THOR-707

· Synthorx, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for THOR-707, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101) [Phase 1, Phase 2]

See pricing